CHLORZOXAZONE 500 MG PLUS DICLOFENAC SODIUM 50 MG PLUS PARACETAMOL 325 MG TAB,ALBENDAZOLE 400 MG TA
Indian Army
ANANTHNAG, JAMMU & KASHMIR
Bid Publish Date
06-Jan-2025, 4:00 pm
Bid End Date
21-Jan-2025, 10:00 am
Location
Progress
Quantity
5085
Category
SYP.Levocetirizine 2.5mg OR 5ml PLUS Montelukast 4mg OR 5ml
Bid Type
Two Packet Bid
Public procurement opportunity for Hindustan Copper Limited SYP. Levocetirizine 2. 5mg OR 5ml PLUS Montelukast 4mg OR 5ml, SYP. Colistin Sulphate 12. 5mg, DROP Simethicone, Emulsion Dil Oil, Fennel Oil, Sucralose Base, SYP. Chlorpheniramine Maleate 2mg OR 5ml PLUS Dextromethorphan Hydrobromide 5mg OR 5ml 60 ml, SYP. Amoxycillin 125mg PLUS Clavulanic Acid 31. 25mg, SYP. Chlorpheniramine Maleate 1mg PLUS Phenylephrine 5mg PLUS Paracetamol 125mg PLUS Sodium Citrate 60mg, SYP. Chlorpheniramine Maleate 0. 5mg OR 5ml PLUS Paracetamol 125mg OR 5ml PLUS Phenylephrine 5mg OR 5ml PLUS Sodium Citrate 60mg OR 5ml PLUS Menthol 1mg OR 5ml, SYP. Ibuprofen 100mg PLUS Paracetamol 162. 5mg, SACHET Racecadotril 15mg PLUS Saccharomyces boulardii 2. 5Billion cells POWDER, SYP Prednisolone 5mg OR 5ml, TAB. Azithromycin 250mg, SYP. Iron 30mg PLUS Folic Acid 500mcg PLUS Vitamin B12 500mcg, DROP. Vitamin D3 IP 400 IU cholecalciferol. , DROP. Benzocaine 2. 7 PERCENTAGE w OR v PLUS Chlorbutol 5 PERCENTAGE w OR v PLUS Paradichlorobenzene 2 PERCENTAGE w OR v PLUS Turpentine Oil 15 PERCENTAGE w OR v, OINT. Miconazole 20mg PLUS Mometasone 1mg PLUS Nadifloxacin 10mg, OINT. Silver Nitrate 0. 2 PERCENTAGE w OR w, GEL Clindamycin 1 PERCENTAGE w OR w PLUS Nicotinamide 4 PERCENTAGE w OR w, SYP. Amoxycillin 400mg OR 5ml PLUS Clavulanic Acid 57mg OR 5ml, SYP. Sorbitol Solution, Sodium Citrate, Propylene Glycol, Sodium, Cellulose, Colloidal Silicon dioxide, Sodium Methyl Paraben, Xanthan Gum, Calcium Phosphorus, Magnesium, D- Mannose, Zinc, Vitamin D3, SYP. Ivermectin 1. 5mg PLUS Albendazole 200mg, TAB. Ivermectin 1. 5mg PLUS Albendazole 200mg, SYP. Granisetron 1mg, Suspension Bacillus clausii, syp. L-lysine, Vitamin A, B3, B5, B6, D, E, Zinc, Iron, Folic acid, Beta- carotene, Manganese, Selenium, Chromium, Biotin, Zinc dry Power for suspention 15 ml, Inj. Noradrenaline Bitartrate, Inj. Amiodaron 150mg, Inj. Calcium Gluconate 10 PERCENTAGE w OR v, Levosalbutamol 1. 25mg PLUS Ipratropium 500mg Respules 3ml, Inj. Lignocaine hydrochloride 2 PERCENTAGE, Amoxycillin 600mg PLUS clavulanic acid 42. 9 ES Syp. , faropenem 100mg Syp. , Arteether 20mg OR ml PLUS Lumefantrine 120mg OR 5ml Syp, Nasivion 0. 0025 PERCENTAGE paediatric Nasal Drop child in BALAGHAT, MADHYA PRADESH. Quantity: 5085 issued by. Submission Deadline: 21-01-2025 10: 00: 00. View full details and respond.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
ANANTHNAG, JAMMU & KASHMIR
Dg Armed Forces Medical Service
PITHORAGARH, UTTARAKHAND
Indian Army
SRINAGAR, JAMMU & KASHMIR
Dg Armed Forces Medical Service
KANNUR, KERALA
Indian Army
RANCHI, JHARKHAND
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | SYP.Levocetirizine 2.5mg OR 5ml PLUS Montelukast 4mg OR 5ml | SYP.Levocetirizine 2.5mg OR 5ml PLUS Montelukast 4mg OR 5ml | 300 | phial | r_khare | 90 |
| 2 | SYP.Colistin Sulphate 12.5mg | SYP.Colistin Sulphate 12.5mg | 100 | phial | r_khare | 90 |
| 3 | DROP Simethicone, Emulsion Dil Oil,Fennel Oil,Sucralose Base | DROP Simethicone, Emulsion Dil Oil,Fennel Oil,Sucralose Base | 30 | phial | r_khare | 90 |
| 4 | SYP.Chlorpheniramine Maleate 2mg OR 5ml PLUS Dextromethorphan Hydrobromide 5mg OR 5ml 60 ml | SYP.Chlorpheniramine Maleate 2mg OR 5ml PLUS Dextromethorphan Hydrobromide 5mg OR 5ml 60 ml | 200 | phial | r_khare | 90 |
| 5 | SYP.Amoxycillin 125mg PLUS Clavulanic Acid 31.25mg | SYP.Amoxycillin 125mg PLUS Clavulanic Acid 31.25mg | 150 | phial | r_khare | 90 |
| 6 | SYP.Chlorpheniramine Maleate 1mg PLUS Phenylephrine 5mg PLUS Paracetamol 125mg PLUS Sodium Citrate 60mg | SYP.Chlorpheniramine Maleate 1mg PLUS Phenylephrine 5mg PLUS Paracetamol 125mg PLUS Sodium Citrate 60mg | 225 | phial | r_khare | 90 |
| 7 | SYP .Chlorpheniramine Maleate 0.5mg OR 5ml PLUS Paracetamol 125mg OR 5ml PLUS Phenylephrine 5mg OR 5ml PLUS Sodium Citrate 60mg OR 5ml PLUS Menthol 1mg OR 5ml | SYP .Chlorpheniramine Maleate 0.5mg OR 5ml PLUS Paracetamol 125mg OR 5ml PLUS Phenylephrine 5mg OR 5ml PLUS Sodium Citrate 60mg OR 5ml PLUS Menthol 1mg OR 5ml | 125 | bottle | r_khare | 90 |
| 8 | SYP.Ibuprofen 100mg PLUS Paracetamol 162.5mg | SYP.Ibuprofen 100mg PLUS Paracetamol 162.5mg | 300 | phial | r_khare | 90 |
| 9 | SACHET Racecadotril 15mg PLUS Saccharomyces boulardii 2.5Billion cells POWDER | SACHET Racecadotril 15mg PLUS Saccharomyces boulardii 2.5Billion cells POWDER | 500 | packet | r_khare | 90 |
| 10 | SYP Prednisolone 5mg OR 5ml | SYP Prednisolone 5mg OR 5ml | 25 | phial | r_khare | 90 |
| 11 | TAB.Azithromycin 250mg | TAB.Azithromycin 250mg | 1,000 | number | r_khare | 90 |
| 12 | SYP.Iron 30mg PLUS Folic Acid 500mcg PLUS Vitamin B12 500mcg | SYP.Iron 30mg PLUS Folic Acid 500mcg PLUS Vitamin B12 500mcg | 250 | phial | r_khare | 90 |
| 13 | DROP.Vitamin D3 IP 400 IU cholecalciferol . | DROP.Vitamin D3 IP 400 IU cholecalciferol . | 100 | phial | r_khare | 90 |
| 14 | DROP.Benzocaine 2.7 PERCENTAGE w OR v PLUS Chlorbutol 5 PERCENTAGE w OR v PLUS Paradichlorobenzene 2 PERCENTAGE w OR v PLUS Turpentine Oil 15 PERCENTAGE w OR v | DROP.Benzocaine 2.7 PERCENTAGE w OR v PLUS Chlorbutol 5 PERCENTAGE w OR v PLUS Paradichlorobenzene 2 PERCENTAGE w OR v PLUS Turpentine Oil 15 PERCENTAGE w OR v | 100 | phial | r_khare | 90 |
| 15 | OINT.Miconazole 20mg PLUS Mometasone 1mg PLUS Nadifloxacin 10mg | OINT.Miconazole 20mg PLUS Mometasone 1mg PLUS Nadifloxacin 10mg | 150 | tube | r_khare | 90 |
| 16 | OINT.Silver Nitrate 0.2 PERCENTAGE w OR w | OINT.Silver Nitrate 0.2 PERCENTAGE w OR w | 250 | tube | r_khare | 90 |
| 17 | GEL Clindamycin 1 PERCENTAGE w OR w PLUS Nicotinamide 4 PERCENTAGE w OR w | GEL Clindamycin 1 PERCENTAGE w OR w PLUS Nicotinamide 4 PERCENTAGE w OR w | 50 | phial | r_khare | 90 |
| 18 | SYP.Amoxycillin 400mg OR 5ml PLUS Clavulanic Acid 57mg OR 5ml | SYP.Amoxycillin 400mg OR 5ml PLUS Clavulanic Acid 57mg OR 5ml | 100 | phial | r_khare | 90 |
| 19 | SYP.Sorbitol Solution, Sodium Citrate, Propylene Glycol, Sodium, Cellulose,Colloidal Silicon dioxide, Sodium Methyl Paraben, Xanthan Gum, Calcium Phosphorus, Magnesium, D-Mannose, Zinc, Vitamin D3 | SYP.Sorbitol Solution, Sodium Citrate, Propylene Glycol, Sodium, Cellulose,Colloidal Silicon dioxide, Sodium Methyl Paraben, Xanthan Gum, Calcium Phosphorus, Magnesium, D-Mannose, Zinc, Vitamin D3 | 100 | phial | r_khare | 90 |
| 20 | SYP.Ivermectin 1.5mg PLUS Albendazole 200mg | SYP.Ivermectin 1.5mg PLUS Albendazole 200mg | 150 | phial | r_khare | 90 |
| 21 | TAB.Ivermectin 1.5mg PLUS Albendazole 200mg | TAB.Ivermectin 1.5mg PLUS Albendazole 200mg | 300 | phial | r_khare | 90 |
| 22 | SYP.Granisetron 1mg | SYP.Granisetron 1mg | 50 | phial | r_khare | 90 |
| 23 | Suspension Bacillus clausii | Suspension Bacillus clausii | 100 | phial | r_khare | 90 |
| 24 | syp.L-lysine,Vitamin A, B3, B5, B6, D, E,Zinc,Iron,Folic acid,Beta-carotene,Manganese,Selenium,Chromium,Biotin | syp.L-lysine,Vitamin A, B3, B5, B6, D, E,Zinc,Iron,Folic acid,Beta-carotene,Manganese,Selenium,Chromium,Biotin | 250 | phial | r_khare | 90 |
| 25 | Zinc dry Power for suspention 15 ml | Zinc dry Power for suspention 15 ml | 25 | phial | r_khare | 90 |
| 26 | Inj. Noradrenaline Bitartrate | Inj. Noradrenaline Bitartrate | 5 | ampule | r_khare | 90 |
| 27 | Inj. Amiodaron 150mg | Inj. Amiodaron 150mg | 5 | ampule | r_khare | 90 |
| 28 | Inj.Calcium Gluconate 10 PERCENTAGE w OR v | Inj.Calcium Gluconate 10 PERCENTAGE w OR v | 5 | ampule | r_khare | 90 |
| 29 | Levosalbutamol 1.25mg PLUS Ipratropium 500mg Respules 3ml | Levosalbutamol 1.25mg PLUS Ipratropium 500mg Respules 3ml | 50 | ampule | r_khare | 90 |
| 30 | Inj.Lignocaine hydrochloride 2 PERCENTAGE | Inj.Lignocaine hydrochloride 2 PERCENTAGE | 10 | vial | r_khare | 90 |
| 31 | Amoxycillin 600mg PLUS clavulanic acid 42.9 ES Syp. | Amoxycillin 600mg PLUS clavulanic acid 42.9 ES Syp. | 30 | phial | r_khare | 90 |
| 32 | faropenem 100mg Syp. | faropenem 100mg Syp. | 10 | phial | r_khare | 90 |
| 33 | Arteether 20mg OR ml PLUS Lumefantrine 120mg OR 5ml Syp | Arteether 20mg OR ml PLUS Lumefantrine 120mg OR 5ml Syp | 10 | phial | r_khare | 90 |
| 34 | Nasivion 0.0025 PERCENTAGE paediatric Nasal Drop child | Nasivion 0.0025 PERCENTAGE paediatric Nasal Drop child | 30 | phial | r_khare | 90 |
Discover companies most likely to bid on this tender
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | GARG MEDICAL STORE Under PMA | - | 17-01-2025 15:27:24 | Evaluated |
| 2 | KOTHARI PHARMA Under PMA | - | 20-01-2025 20:31:23 | Evaluated |
| 3 | Om Medical Store Under PMA | - | 21-01-2025 03:50:42 | Evaluated |
| 4 | RAKTI LIFE CARE Under PMA | - | 20-01-2025 19:41:52 | Evaluated |
| 5 | SUSHANT ENTERPRISES Under PMA | - | 13-01-2025 18:46:46 | Evaluated |
| 6 | VAISHNAV HEALTHCARE Under PMA | - | 20-01-2025 21:24:25 | Evaluated |
Key insights about MADHYA PRADESH tender market
The eligibility requirements include being a registered entity with relevant experience in healthcare procurement, compliance with regulatory standards for manufacturing and supply, and possession of necessary licenses for the distribution of pharmaceuticals.
Bidders must provide documentation such as proof of registration, manufacturing licenses, quality assurance certifications, and any relevant credentials to showcase compliance with health regulations.
To register, interested bidders must submit their complete company information along with the required documents in an electronic format. All submissions should adhere to the guidelines mentioned in the tender documents.
Submissions must be made electronically in PDF format to ensure security and ease of access. All required documents should be clearly labeled and organized.
All medicines must comply with established quality standards, including precise labeling of active ingredients, manufacturing details, and expiration information.
Yes, products must adhere to quality standards set forth by health regulatory authorities, guaranteeing that the pharmaceuticals are safe and effective for patient use.
Bidders must comply with local laws and regulations pertaining to the production and distribution of medicines, including maintaining relevant licenses and documentation as evidence of compliance.
The EMD amount and specific requirements will be detailed in the tender documents, ensuring that bidders confirm their commitment to participate in the tender process.
A performance security may be required and should reflect a percentage of the total contract value to guarantee adherence to the bidding terms and supply commitments.
Details regarding payment terms, including schedules and acceptable methods, will be outlined in the final contract agreement with the selected vendor.
The financial evaluation will focus on ensuring competitiveness while considering the quality and compliance of the products being offered in relation to market standards.
Bids should be submitted electronically by the specified deadline, ensuring all required documents are included and comply with the tender specifications.
While specific deadlines detail submission and evaluation processes, bidders must regularly check the official tender notice for updates as they progress.
The evaluation process comprises preliminary screenings based on eligibility, followed by thorough technical reviews and financial evaluations to determine the best fit for the requirements.
Yes, all bidders will receive notifications regarding the outcomes of the evaluation process, including both successful and unsuccessful submissions.
Yes, MSEs may benefit from preferential treatment in the evaluation process, encouraging their participation and contributions to healthcare supply chains.
Startups are encouraged to participate in this tender and may be provided with specific considerations to promote their engagement and development within the healthcare sector.
The tender supports local manufacturing in line with 'Make in India' initiatives, promoting the procurement of medicines produced within the country to enhance local industry growth.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS